PapersFlow Research Brief
Pluripotent Stem Cells Research
Research Guide
What is Pluripotent Stem Cells Research?
Pluripotent stem cells research is the study of induction, differentiation, and reprogramming of pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells, to model development, disease, and tissue regeneration.
The field encompasses transcriptional regulatory circuitry, neural and cardiac differentiation, epigenetic memory, and reprogramming using defined factors. Over 80,761 works address these topics in molecular biology. Research demonstrates methods to derive human embryonic stem cell lines from blastocysts and induce pluripotency from somatic cells.
Topic Hierarchy
Research Sub-Topics
Induced Pluripotent Stem Cell Reprogramming
This sub-topic details the molecular mechanisms and optimization of iPSC generation from somatic cells using transcription factors like Oct4 and Sox2. Researchers focus on efficiency, safety, and non-viral methods.
Neural Differentiation from Pluripotent Stem Cells
Scholars study protocols for directing PSCs to neurons, glia, and organoids, modeling neurodevelopment and diseases like Parkinson's. This includes signaling pathways and maturation challenges.
Cardiac Differentiation of Pluripotent Stem Cells
This sub-topic covers protocols for generating functional cardiomyocytes from ESCs/iPSCs, including purification and electrophysiological maturation. Applications target heart disease modeling and drug screening.
Epigenetic Memory in Reprogrammed Stem Cells
Researchers investigate residual somatic epigenetic marks in iPSCs that bias differentiation potential and lineage priming. Studies employ ChIP-seq and CRISPR editing to erase memory.
Transcriptional Regulatory Networks in Pluripotency
This sub-topic maps core pluripotency circuits involving Nanog, Oct4, and Sox2, using systems biology and single-cell RNA-seq. It explores maintenance, exit, and species differences.
Why It Matters
Pluripotent stem cells research enables derivation of embryonic stem cell lines from human blastocysts that maintain normal karyotypes and high telomerase activity for prolonged undifferentiated proliferation (Thomson et al. (1998) "Embryonic Stem Cell Lines Derived from Human Blastocysts"). Induced pluripotent stem cells from mouse embryonic and adult fibroblasts using four defined factors—Oct3/4, Sox2, c-Myc, and Klf4—offer a source of patient-specific cells for disease modeling and transplantation without ethical issues of embryos (Takahashi and Yamanaka (2006) "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors"). Human fibroblasts reprogrammed with similar factors produce pluripotent cells applicable to regenerative medicine, as shown by Takahashi et al. (2007) with 19,855 citations. These advances support tissue regeneration, such as cardiomyocytes from differentiated stem cells, and matrix elasticity influencing lineage specification (Engler et al. (2006) "Matrix Elasticity Directs Stem Cell Lineage Specification").
Reading Guide
Where to Start
Start with "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors" by Takahashi and Yamanaka (2006) because it introduces the core concept of reprogramming somatic cells to pluripotency using four defined factors, foundational for understanding induced pluripotent stem cells.
Key Papers Explained
Takahashi and Yamanaka (2006) "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors" first demonstrated iPSC generation in mice with Oct4, Sox2, c-Myc, Klf4. Takahashi et al. (2007) "Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors" extended this to human fibroblasts using the same factors. Yu et al. (2007) "Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells" refined human iPSC production with OCT4, SOX2, NANOG, LIN28, avoiding c-Myc for safety. Thomson et al. (1998) "Embryonic Stem Cell Lines Derived from Human Blastocysts" provides the baseline for comparing iPSCs to human embryonic stem cells. Evans and Kaufman (1981) "Establishment in culture of pluripotential cells from mouse embryos" established the initial mouse embryonic stem cell methods.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers involve refining differentiation protocols for neural and cardiac lineages, building on transcriptional regulation from foundational papers. Epigenetic remodeling during reprogramming remains active, as implied in iPSC induction works. No recent preprints or news available indicate focus persists on core applications like disease modeling and regeneration.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Induction of Pluripotent Stem Cells from Mouse Embryonic and A... | 2006 | Cell | 26.1K | ✓ |
| 2 | Induction of Pluripotent Stem Cells from Adult Human Fibroblas... | 2007 | Cell | 19.9K | ✕ |
| 3 | Embryonic Stem Cell Lines Derived from Human Blastocysts | 1998 | Science | 15.8K | ✕ |
| 4 | Potent and specific genetic interference by double-stranded RN... | 1998 | Nature | 15.1K | ✕ |
| 5 | Matrix Elasticity Directs Stem Cell Lineage Specification | 2006 | Cell | 13.5K | ✓ |
| 6 | Stages of embryonic development of the zebrafish | 1995 | Developmental Dynamics | 12.0K | ✕ |
| 7 | Induced Pluripotent Stem Cell Lines Derived from Human Somatic... | 2007 | Science | 10.2K | ✕ |
| 8 | Establishment in culture of pluripotential cells from mouse em... | 1981 | Nature | 8.5K | ✕ |
| 9 | 3D bioprinting of tissues and organs | 2014 | Nature Biotechnology | 6.6K | ✕ |
| 10 | Mesenchymal stem cells | 1991 | Journal of Orthopaedic... | 6.5K | ✕ |
Frequently Asked Questions
What factors induce pluripotency in mouse somatic cells?
Takahashi and Yamanaka (2006) identified Oct3/4, Sox2, c-Myc, and Klf4 as defined factors that induce pluripotent stem cells from mouse embryonic and adult fibroblast cultures. These cells exhibit properties of embryonic stem cells, including pluripotency. The method bypasses the need for embryonic sources.
How are human embryonic stem cell lines derived?
Thomson et al. (1998) derived human embryonic stem cell lines from blastocysts, which display normal karyotypes, high telomerase activity, and primate embryonic stem cell markers. These lines proliferate indefinitely while remaining undifferentiated. They do not express markers of other early lineages.
What distinguishes induced pluripotent stem cells from human somatic cells?
Yu et al. (2007) used OCT4, SOX2, NANOG, and LIN28 to reprogram human somatic cells into induced pluripotent stem cell lines. These cells match embryonic stem cells in pluripotency and gene expression. The approach relies on oocyte-like reprogramming factors without nuclear transfer.
How does matrix elasticity affect stem cell differentiation?
Engler et al. (2006) showed that matrix elasticity directs stem cell lineage specification toward lineages like muscle, neuron, or bone. Soft matrices favor neuronal differentiation, while rigid ones promote osteogenic paths. This mechanical cue influences mesenchymal stem cell fate.
What is the historical origin of mouse pluripotent cell culture?
Evans and Kaufman (1981) established pluripotential cells from mouse embryos in culture. These cells demonstrated self-renewal and differentiation potential. The work laid the foundation for embryonic stem cell research.
How many works exist in pluripotent stem cells research?
The field includes 80,761 works focused on induction, differentiation, and reprogramming. Topics cover embryonic and induced pluripotent stem cells. Growth data over five years is not available.
Open Research Questions
- ? How can epigenetic memory from somatic cells be fully erased during reprogramming to match embryonic stem cell fidelity?
- ? What optimized combinations of defined factors minimize tumorigenesis risk in induced pluripotent stem cells?
- ? How do mechanical cues like matrix elasticity integrate with transcriptional regulation to control cardiac differentiation?
- ? Which culture conditions best maintain long-term pluripotency without genetic instability in human lines?
- ? How does transcriptional circuitry differ between mouse and human induced pluripotent stem cells during neural differentiation?
Recent Trends
The field maintains 80,761 works with no specified five-year growth rate.
Highly cited papers from 1981 to 2007, such as Takahashi and Yamanaka with 26,108 citations and Takahashi et al. (2007) with 19,855 citations, continue to define reprogramming standards.
2006No recent preprints or news coverage in the last 12 months signals steady consolidation of established methods rather than new surges.
Research Pluripotent Stem Cells Research with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pluripotent Stem Cells Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers